Pharmaceutical Products Division, Department of Integrative
Pharmacology and Gastroenterology Venture, Abbott Laboratories,
Abbott Park, Illinois
 |
Introduction |
Gastric
emptying (GE) is delayed in diseases such as diabetes mellitus
(Horowitz et al., 1986
, 1987
; Brogna et al., 1989
; Janssens et al.,
1990
; Schmid et al., 1991
; Peeters et al., 1992
) and functional
dyspepsia (Corinaldesi et al., 1987
; Davis et al., 1988
). Gastric
emptying also is delayed in as many as 50% of patients after truncal
vagotomy, antrectomy, and Roux-Y gastrojejunostomy (Hocking et al.,
1981
; Vogel et al., 1983
; Carlson et al., 1991
). The common factor in
these conditions is upper gastrointestinal motor dysfunction.
Therefore, a prokinetic drug with a primary site of action in the upper
gut (stomach, and first half of the small intestine) might provide
benefit in treatment of these disorders.
Motilin, a 22-amino acid peptide, has been shown to accelerate GE
in normal subjects (Christofides et al., 1979
, 1981
) and in patients
with diabetic gastroparesis (Schmid et al., 1991
; Peeters et al., 1992
)
when given as an i.v. infusion. Motilin is thought to accelerate GE by
increasing the force of postprandial antral contractions and by
promoting coordination between antral and duodenal motor activity
(Annese et al., 1992
). Erythromycin (ERY), a 14-membered macrolide with
antibiotic activity, binds to motilin receptors in the antrum and
duodenum (Peeters et al., 1989
). It also stimulates contractile
activity similar to motilin (Annese et al., 1992
). Additionally, ERY
accelerated GE in normal subjects and in diabetic gastroperetic
patients to the same extent as motilin (Janssens et al., 1990
).
ABT-229
(8,9-anhydro-4"-deoxy-3'-N-desmethyl-3'-N-ethylerythromycin
B-6,9-hemiacetal) is a more potent synthetic derivative of ERY with no
antibiotic activity (Lartey et al., 1995
, Faghih et al., 1998
). As with
ERY, ABT-229 is thought to stimulate contractile activity through
activation of motilin receptors (Clark et al., 1999
). Previously,
ABT-229 has been reported to stimulate contractile activity of the
antrum and small intestine in fasted conscious dogs (Faghih et al.,
1998
). The objective of this study was to determine the effect of
ABT-229 on GE of a solid meal as well as postprandial motor activity of
the antrum and duodenum, and to compare them with the effects of
cisapride (CIS) and ERY.
 |
Materials and Methods |
Experiments were conducted on six conscious beagle dogs,
weighing 9.5 to 11.3 kg and trained to stand in a sling. The procedures used in this study were approved by the Institutional Animal Care and
Use Committee of Abbott Laboratories, Abbott Park, IL.
Surgical Preparation.
After an overnight fast, dogs were
initially anesthetized with thiopental, 20 mg/kg i.v., and prepared for
surgery in accordance with standard procedures. Isoflurane (1-1.5%)
delivered via a semiclosed system was used during the surgical
procedure as a general anesthetic. Through a midventral laparotomy, a
silicon catheter (3.2-mm o.d. × 1.6-mm i.d.) was placed intraluminally with its tip 2 cm distal to the pylorus. A stainless steel collection cannula was placed 20 cm distal to the pylorus. Additionally, two
strain gage force transducers (RB Products, Stillwater, MN) were
sutured to the serosal surface of the antrum 2 and 5 cm proximal to the
pylorus, and four transducers were placed on the duodenum 2, 6, 10, and
14 cm distal to the pylorus. The catheter was tunneled s.c. to the
midscapular region and connected to an s.c. access port (Access
Technologies, Skokie, IL). The abdominal incision was closed in two
layers. An access port catheter also was inserted into the external
jugular vein. At least 2 weeks were allowed for recovery from surgery.
Experiments were initiated only after the animals were consuming a
normal diet.
Recording and Analysis of Contractile Activity.
Contractile
activity was recorded with a Grass polygraph (model 7) equipped with
7P1 low-level d.c. preamplifiers and 7DA driver amplifiers. The signals
were simultaneously digitized at 10 Hz into computer files for
identification of individual contractions and determination of the area
under each contraction. Each record was analyzed from time of feeding
until 90% of the meal had emptied; the data are expressed as the
average motility index (area/minute) during that time. The area of each
contraction at each site was standardized to the mean area of the 10 largest contractions during phase III activity at that site. This was
done to account for differences between sensitivities of transducers at
different sites. Additionally, the records were inspected visually for
phenomena the computer program might not recognize, such as
gastroduodenal coordination. Gastroduodenal coordination was defined as
a contraction or group of contractions that originated in the antrum,
while the duodenum was quiescence, and then propagated aborad into the duodenum within 10 s, migrating through the duodenum at a constant velocity.
Experimental Protocol.
After an overnight fast, dogs were
placed in a sling for GE studies. Beginning 30 min before the animals
were fed, a solution containing a nonabsorbable marker [polyethylene
glycol 4000 (PEG)] was perfused at 0.5 ml/min through the duodenal
catheter and continued for the remainder of the experiment.
Simultaneously, an i.v. infusion of either vehicle, ABT-229 (0.17, 0.83, 2.5, or 5.0 µg/kg/min), CIS (10 µg/kg/min), or ERY (33.3 µg/kg/min) was initiated and continued for 30 min at a volume rate of
0.24 ml/min. At the end of the drug infusion, the dogs were fed
175 g of commercial dog food (Alpo Prime Cuts) mixed thoroughly
with 125 mg of chromium oxide
(Cr2O3), a solid-phase
marker. After feeding, chyme samples were collected every 5 min for the
first 30 min to identify the lag phase of the GE curve. After this
point, samples were collected at 40 and 50 min and then at 20-min
intervals until solid food particles were no longer present.
Sample Analysis and Calculation of GE.
The samples were
centrifuged at 2000 rpm for 20 min, and the volumes of the supernatant
(Vln) and the solid pellet
(Vsn) were measured. One milliliter of
the supernatant (PEGl) and perfusion solution
(PEGp) were used to determine the PEG
concentrations by the method of Malawer and Powell (1967)
. The
concentration of Cr2O3 was
measured from the sediment of each sample by the method of Bolin et al.
(1952)
.
The equations used to determine GE were previously derived and reported
by Orihata and Sarna (1994a
,b
). Mean flow rate
(FRln) of the liquid fraction of the chyme for
each sample (n) was calculated as follows:
where [PEGp] and
[PEGl]n are the
concentrations of PEG in the perfusion solution and nth
sample of the liquid phase, respectively, and PR is the perfusion rate
in milliliters per minute.
The mean flow rate for the solids (FRsn) of each
sample (n) was determined as follows:
The amount of solid meal that passes the cannula for each
sample is derived as follows:
where SMEn is solid meal emptied for
interval n,
[Cr2O3]n
is the concentration of
Cr2O3 for the
nth sample, and tn is the
duration of the nth sample interval.
The percentage of the total meal passing the cannula during each sample
interval was calculated as follows:
where m is the total number of samples.
The GE curve is constructed as the cumulative addition of the %SME at
each time point (T).
Data Analysis. The beginning of the meal defines zero
time. GE occurs in three phases: lag phase, linear phase, and postlinear phase. The lag phase was defined as the time from the beginning of the meal until 5% of the meal was emptied. The
half-emptying time (t1/2) was defined
as the time postprandially when 50% of the meal was emptied. The total
GE time (tfull) was defined as the
time when 90% of the meal was emptied. The slope of the linear phase
of each GE curve (GE rate) was calculated with a linear regression
model for the points between the end of the lag phase and the 90%
(tfull) emptied point (Camilleri et
al., 1989
; Iwanaga et al., 1998
). The goodness of fit of the linear
regression was determined from the square of the correlation
coefficient (r2). All data are
expressed as either the mean ± S.E. or the median with 25 to 75 percentiles. One-way ANOVA with repeated measures was used to determine
whether there was a difference between mean values for parametric data.
For nonparametric data the Friedman ANOVA with repeated measures was
used to determine whether there was a difference between median values.
When a difference was found, the Student-Newman-Kruls post hoc test was
used to determine which means or medians were different. A P
value of
.05 was considered to indicate a significant difference.
Drugs. ABT-229 lactobionate and ERY lactobionate were
synthesized by Abbott Laboratories. CIS was synthesized by R. Faghih
(Abbott Laboratories). All doses refer to dose equivalents of compound
free base. ABT-229 and ERY were dissolved in sterile water for
injection (Abbott Laboratories) and CIS was dissolved in 1% lactic
acid and adjusted to pH 3 to 4. Dosing solutions were prepared fresh
for each experiment.
 |
Results |
GE.
ABT-229 dose dependently accelerated GE compared with
vehicle (Fig. 1). CIS and ERY also
accelerated GE at the doses tested (Fig. 1). ABT-229 at the two highest
doses significantly decreased the lag phase, as did CIS compared with
vehicle (Fig. 2). Additionally, there was
a significant difference in tlag
between the 0.17 and 0.83 µg/kg/min doses of ABT-229, as well as ERY
and the two highest doses of ABT-229 (Fig. 2). ABT-229 at the three
highest doses, in addition to ERY and CIS, significantly decrease
t1/2 compared with vehicle (Fig. 2).
Compared with vehicle, tfull was
significantly decreased by all doses of ABT-229, as well as by ERY and
CIS (Fig. 2). The GE rate during the linear phase was significantly
increased by all doses of ABT-229, as well as by ERY and CIS compared
with vehicle (Table 1); however, there
was no difference in GE rate between doses of ABT-229 and/or between
CIS and ERY. In all experiments, the regression coefficient for the
linear phase was >0.9.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 1.
Cumulative mean GE curves of a solid meal in response
to ABT-229, ERY, and CIS. All compounds significantly increase the
slope compared with vehicle.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of ABT-229, ERY, and CIS on the duration of
the GE lag phase (tlag),
t1/2, and tfull.
n = 6; *P < .05 compared with
control; P < .05 compared with 2.5;
§P < .05 compared with 5.0.
|
|
Postprandial Contractile Activity.
Two types of coordinated
gastroduodenal contractile activity were observed (Figs.
3 and 4).
At the two highest doses of ABT-229 and with CIS, a contractile pattern
was induced that was characterized by a high amplitude (equal to the
maximum amplitude observed during phase III activity) propagated antral
contraction with quiescence in the duodenum. A migrating cluster of
contractions in the duodenum then followed the antral contraction. This
type of coordinated activity occurred during the first 60 min after the
meal (Fig. 3). The frequency of this type of coordinated contractile
pattern was significantly increased compared with vehicle and with the two lowest doses of ABT-229 and ERY (Table
2).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 3.
Recording illustrating high-amplitude, coordinated
gastroduodenal contractile activity. This type of activity was seen in
the first 60 min postprandially at the two highest doses of ABT-229 and
with CIS. Note the quiescence in the duodenum during the antral
contraction. Arrows indicate coordinated contractile activity. A,
antrum and D, duodenum and the number after A and D indicates the
distances of the transducers from the pylorus.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
Recording illustrating low-amplitude, coordinated
gastroduodenal contractile activity. This type of activity was recorded
throughout the postprandial period with all doses of ABT-229, as well
as with CIS and ERY. Note the quiescence in the duodenum during the
antral contraction. Arrows indicate coordinated contractile activity.
A, antrum and D, duodenum and the number after A and D indicates the
distances of the transducers from the pylorus.
|
|
The second type of coordinated antral duodenal activity (Fig. 4) was
characterized by a propagated antral contraction of normal postprandial
amplitude (15-20% of maximal phase III activity amplitude) with
quiescence in the duodenum in at least the first two recording sites.
The antral contraction was followed by a propagated duodenal contraction. ABT-229 caused a dose-dependent increase in this low-amplitude, coordinated activity, with the increase compared with
vehicle becoming significant at 0.17 µg/kg/min and higher doses. ERY
and CIS also significantly increased this type of coordinated activity
at the doses tested (Table 3).
There was also a dose-dependent increase in the motility index of both
the antrum and duodenum with ABT-229, which became significant at doses
of 0.83 µg/kg/min and higher (Fig. 5).
Additionally, both CIS and ERY significantly increased the postprandial
motility index (Fig. 5).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of ABT-229, ERY, and CIS on the motility index
of the antrum and duodenum. *P < .05 compared with
vehicle.
|
|
 |
Discussion |
The rate of GE is a function of the difference in pressures
between the stomach and duodenum and of resistance to flow across the
gastroduodenal junction (Kelly, 1981
). Therefore, a compound that
stimulates antral contractions, while the duodenum is quiescence, would
be expected to increase flow across the gastroduodenal junction. Additionally, if propagated duodenal contractions occur after the
antral contraction, the chyme would be carried away, reducing resistance to flow across the gastroduodenal junction when the next
antral contraction occurs. This type of contractile activity is
classified as gastroduodenal coordination (Kelly, 1981
). In contrast,
if duodenal contractions occur at the same time as the antral
contraction, the pressure gradient across the gastroduodenal junction
would be decreased and there would be less flow. All three compounds
examined in this study induced gastroduodenal coordination.
ERY has previously been shown to be a gastrokinetic agent in both
animals (Lin et al., 1994
) and humans (Annese et al., 1992
; Tack et
al., 1992
). ERY is thought to exercise its gastrokinetic effects by
increasing the motility of the antrum (Annese et al., 1992
; Tack et
al., 1992
), increasing proximal gastric tone (Bruley DesVarannes et
al., 1995
), and increasing the coordination between antral and duodenal
contractions (Annese et al., 1992
; Tack et al., 1992
). At the dose of
ERY used in this study, we also observed an increase in antral motility
and gastroduodenal coordination.
This study shows that ABT-229, a synthetic derivative of ERY without
antibiotic activity (Lartey et al., 1995
; Faghih et al., 1998
), dose
dependently accelerated gastric emptying of a solid meal by decreasing
the lag phase and increasing the rate of GE during the linear phase.
Additionally, ABT-229 increased postprandial contractile activity and
gastroduodenal coordination in the dog. Depending on the parameter
examined, ABT-229 appears to be ~7- to 40-fold more potent than ERY
in the conscious dog.
GE may be accelerated by at least two mechanisms with ABT-229. First,
at the two highest doses of ABT-229, the lag phase was significantly
decreased, probably as a result of high-amplitude, coordinated
gastroduodenal contractions observed in the early postprandial period.
It is also likely that ERY would have stimulated high-amplitude,
coordinated activity in the dog if given at a higher dose than in this
study. In humans, ERY has been reported to stimulate high-amplitude,
coordinated gastroduodenal contractile activity (Annese et al., 1992
)
and in dogs to decrease the lag phase at higher doses than were used in
this study (Lin et al., 1994
). CIS also had been reported to decrease
the lag phase, which is probably a result of the induction of
high-amplitude, coordinated gastroduodenal contractile activity
(Schuurkes, 1990
). Second, GE may be accelerated through both the
stimulation of low-amplitude, coordinated gastroduodenal contractile
activity and an increase in motility index observed throughout the
linear phase of GE. These factors are probably the cause of increased
GE rate and appear to be shared by ABT-229, ERY, and CIS.
There is a third possible mechanism by which ABT-229 may enhance GE
rate. Previously, ERY has been reported to increase postprandial proximal gastric tone and pressure in humans (Bruley DesVarannes et
al., 1995
). We did not, however, measure gastric tone in this study, so
it remains to be determined if increased GE rate in dog is triggered by
a rise in proximal gastric tone.
In conclusion, we have shown that ABT-229 dose dependently accelerates
GE by increasing postprandial gastroduodenal coordination and by
increasing the motility index. Furthermore, ABT-229 is ~7- to 40-fold
more potent than ERY in this regard.
Accepted for publication February 2, 2000.
Received for publication November 15, 1999.